![]() | ![]() |
Formats:
|
||||||||||||||||
A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination Department of Neurosciences, Center for Gene Expression and Drug Discovery, Beckman Research Institute of City of Hope, 1500 E. Duarte Rd, Duarte, CA 91010 Correspondence should be addressed to Y.S. email: yshi/at/coh.org The publisher's final edited version of this article is available at Nat Struct Mol Biol. See commentary "miR-9 and TLX: chasing tails in neural stem cells." in Nat Struct Mol Biol, volume 16 on page 346. See other articles in PMC that cite the published article.Summary MicroRNAs are important players in stem cell biology. Among them, microRNA-9 (miR-9) is expressed specifically in neurogenic areas of the brain. Whether miR-9 plays a role in neural stem cell self-renewal and differentiation is unknown. We showed previously that nuclear receptor TLX is an essential regulator of neural stem cell self-renewal. Here we show that miR-9 suppresses TLX expression to negatively regulate neural stem cell proliferation and accelerate neural differentiation. Introducing a TLX expression vector lacking the miR-9 recognition site rescued miR-9-induced proliferation deficiency and inhibited precocious differentiation. In utero electroporation of miR-9 in embryonic brains led to premature differentiation and outward migration of the transfected neural stem cells. Moreover, TLX represses miR-9 pri-miRNA expression. MiR-9, by forming a negative regulatory loop with TLX, establishes a model for controlling the balance between neural stem cell proliferation and differentiation. Keywords: nuclear receptor, TLX (NR2E1), microRNA, neural stem cells, proliferation, differentiation Introduction One of the most important issues in stem cell biology is to understand the molecular mechanisms underlying stem cell self-renewal and differentiation. Neural stem cells are a subset of undifferentiated precursors that retain the ability to proliferate and self-renew, and have the capacity to give rise to both neuronal and glial lineages1-4. Although the functional properties of neural stem cells have been studied extensively, how self-renewal and differentiation of neural stem cells is regulated is not completely understood. Accumulating evidence indicates that both transcriptional and post-transcriptional regulation are important mechanisms for regulating genes that are essential for neural stem cell self-renewal and neurogenesis. MicroRNAs (miRNAs) are a recently identified large family of 20-22 nucleotide non-coding RNAs that are involved in numerous cellular processes, including development, proliferation, and differentiation5,6. MiRNAs are thus potentially key post-transcriptional regulators in stem cell self-renewal and differentiation. Distinct sets of miRNAs have been shown to be specifically expressed in embryonic stem cells7,8. Loss of Dicer1 causes embryonic lethality and loss of stem cell populations9,10. Argonaute family members, key components of the RNA-induced silencing complex (RISC), are required for maintaining germline stem cells in various species11. These observations together support a role for miRNAs in stem cell biology. Several brain-specific miRNAs have been identified recently. Among these miRNAs, miR-9 is expressed specifically in neurogenic regions of the brain during neural development and in adulthood12-15. Whether miR-9 plays a role in neural stem cell self-renewal and differentiation remains to be determined. We have shown that TLX is an essential regulator of neural stem cell self-renewal16. TLX maintains adult neural stem cells in an undifferentiated and self-renewable state, in part through transcriptional repression of its downstream target genes, p21 and pten, by complexing with histone deacetylases17. Recently, TLX-positive neural stem cells have been shown to play a role in spatial learning and memory18. In addition to its function in adult brains, TLX also plays an important role in neural development by regulating cell cycle progression in neural stem cells of the developing brain19-21. TLX is therefore a key regulator that acts to establish the undifferentiated and self-renewable state of neural stem cells, though aspects of its regulation are enigmatic. Here we demonstrate that miR-9 suppresses TLX expression by binding to the 3′ untranslated region (UTR) of TLX mRNA, which, in turn, regulates neural stem cell proliferation and differentiation. Increased expression of miR-9 led to reduced mouse neural stem cell proliferation and accelerated neural differentiation, whereas antisense-knockdown of miR-9 led to increased neural stem cell proliferation. Introducing a TLX expression vector lacking the endogenous TLX 3′ UTR rescued miR-9 overexpression-induced proliferation deficiency and reversed miR-9 promoted precocious differentiation. This result suggests that miR-9 regulates neural stem cell proliferation and differentiation, at least in part, through targeting TLX mRNA via its 3′ UTR. In utero electroporation of miR-9 into ventricular zone neural stem cells in embryonic mouse brains triggered premature differentiation and outward migration of the transfected cells, similar to that induced by electroporation of TLX siRNA21. Furthermore, TLX binds to the 3′ genomic sequences of miR-9-1 to inhibit its expression. MiR-9 and TLX thus form a feedback loop to regulate the switch of neural stem cell proliferation and differentiation. Results MiR-9 represses TLX expression by targeting its 3′ UTR We hypothesized that TLX could be targeted by miRNAs to regulate its expression. Using the miRanda (http://www.microrna.org)22 and TargetScan (http://genes.mit.edu/targetscan)23 algorithms, miR-9 was predicted to have a target site in the TLX 3′ UTR. This target site is conserved in human, mouse, dog and chicken TLX (Supplementary Fig. 1a). Since TLX is specifically expressed in vertebrate forebrains and is an essential regulator of neural stem cell self-renewal, we first asked whether the candidate TLX-targeting miR-9 is expressed in the brain, and specifically, whether this miRNA is expressed in neural stem cells or in their differentiated progeny. As shown in Supplementary Fig. 1b, miR-9 is expressed specifically in the brain as revealed by Northern blotting, consistent with previous reports12,13,24. The size of the miRNA is as expected for the mature miR-9 (22 bp). MiR-9 is also expressed in neural stem cells (d0, Fig. 1a
To validate whether miR-9 targets TLX, we made a luciferase reporter construct with mouse 1.4 kb TLX 3′ UTR containing the predicted miR-9 target site and flanking sequences inserted into the 3′ UTR of a Renilla luciferase reporter gene in a siCHECK vector. Increasing amounts of RNA duplexes of mature miR-9 were transfected into human embryonic kidney HEK 293 cells along with the corresponding reporter gene. Dose-dependent repression of the reporter gene was observed in miR-9-treated cells (Fig. 1c Next we tested whether miR-9 targets TLX in neural stem cells. Mature miR-9 RNA duplexes were transfected into neural stem cells. TLX expression levels in transfected cells were examined by Western blot and Northern blot analyses. Marked reduction of TLX protein levels and mRNA levels were detected in miR-9 transfected cells (Fig. 1f, g MiR-9 regulates neural stem cell fate determination To examine whether miR-9 regulates neural stem cell proliferation, neural stem cells were transfected with increasing concentrations of miR-9 RNA duplexes. Cell proliferation was determined by 5-bromodeoxyuridine (BrdU) labeling of dividing cells. Transfection of miR-9 led to dose-dependent inhibition of cell proliferation (Fig. 2a, b
To determine whether overexpression of miR-9 regulates neural stem cell differentiation, neural stem cells were transfected with miR-9 RNA duplexes and cultured under different conditions. Since complete withdrawal of EGF and FGF led to considerable cell death (data not shown), neural stem cells were cultured in N2-supplemented media with low EGF and FGF concentrations (1 ng ml− 1), which allowed cell viability with minimal cell proliferation. Over a 7-day time course, no difference in neuronal and glial differentiation could be detected between control RNA and miR-9 transfected cells (data not shown), suggesting that overexpression of miR-9 alone is not sufficient to trigger neuronal or glial differentiation. However, when neural stem cells were induced for differentiation using forskolin or retinoic acid, transfection of miR-9 promoted both astroglial and neuronal differentiation, leading to an increase in the percentage of GFAP-positive astrocytes and Tuj1-positive neurons at day 3 of differentiation (Fig. 2d, e To determine whether the effect of miR-9 transfection on neural stem cell proliferation and differentiation is mediated through TLX, neural stem cells were stably transduced with a TLX-expressing vector (TLXΔ3′ UTR), which lacks the TLX 3′ UTR. Transfection of miR-9 had no effect on the expression of TLXΔ3′ UTR, although miR-9 downregulated endogenous TLX expression levels (Fig. 3a
Using 2′-O-methyl antisense RNA oligonucleotides as small RNA inhibitors28,29, the role of miR-9 in neural stem cell proliferation was further investigated. 2′-O-methyl antisense oligonucleotide against miR-9 was synthesized and transfected into neural stem cells with 2′-O-methyl antisense oligonucleotide against green fluorescent protein (GFP) included as a negative control. Treatment of antisense oligonucleotides against miR-9 led to substantial knockdown of miR-9 mature forms (Fig. 4a
MiR-9 stimulates neural differentiation in the brain During development, neural stem cells reside in the ventricular zone and migrate out into cortical plate upon differentiation. To determine whether miR-9 influences neural stem cell proliferation and differentiation in vivo, miR-9 RNA duplexes were introduced into neural stem cells in the ventricular zone of E13.5 mouse brains by in utero electroporation. Electroporated brains were analyzed at E15.5. Cells that had taken up miR-9 were labeled green by co-expression of GFP. Transfection of miR-9 led to a marked decrease of cells that were positively labeled for Ki67, a proliferative marker (Fig. 5a
Immunostaining revealed that transfection of miR-9 led to decreased TLX expression (Fig. 5d In addition to neuronal differentiation, we also examined whether miR-9 plays a role in glial differentiation in vivo. Gliogenesis occurs from late embryonic stage through to the early postnatal stage30. MiR-9 RNA duplexes were electroporated into ventricular zone of E14.5 brains. Glial differentiation was analyzed at E17.5 by GFAP staining. Increased GFAP-positive cells were detected in miR-9-transfected cells, compared to that in miR-9 mutant-transfected cells (Supplementary Fig. 4), suggesting that miR-9 overexpression also promotes astroglial differentiation in vivo. Regulation of miR-9 gene expression by TLX Three genes, miR-9-1, miR-9-2 and miR-9-3, encode miR-9 in the mouse genome. Both miR-9-1 and miR-9-2 have been shown to be expressed in mammalian brains14, whereas miR-9-3 has not been detected in vertebrate brains31. To determine whether miR-9 gene expression is affected by TLX expression, RT-PCR analysis was performed to assess the expression levels of miR-9-1 and miR-9-2 pri-miRNAs in brains of wild type and TLX-null mice. Interestingly, the expression of both miR-9-1 and miR-9-2 pri-miRNAs was upregulated in brains of TLX null mice (Fig. 6a
Sequence analysis revealed several consensus TLX binding sites in the flanking regions of miR-9-1 (Fig. 6b Consistent with TLX binding to miR-9-1 genomic sequences, the TLX-interacting transcriptional corepressor HDAC5 was also detected on the TLX binding sites, TLX-1/2 and TLX-3, in the miR-9-1 genomic locus (Fig. 6d To validate the regulation of miR-9-1 gene expression by TLX, we cloned the 1.2 kb miR-9-1 downstream genomic sequence that contains the consensus TLX binding sites, TLX-1/2 and TLX-3, and inserted it downstream of a Renilla luciferase reporter gene in the siCHECK vector. Co-transfection of TLX with the reporter gene in neural stem cells led to 2.2-fold repression of the reporter activity (Fig. 6e Discussion We show here that microRNA miR-9 and nuclear receptor TLX forms a feedback regulatory loop to regulate neural stem cell proliferation and differentiation. TLX is highly expressed in neural stem cells but is repressed upon differentiation16, in contrast, the level of the miR-9 mature form is increased upon differentiation13,24,36. The temporal relationship between miR-9 and TLX expression resembles that between miR-124 and its target genes lamc1, itgb1, and REST32,37,38. In both instances, miRNA targets are preferentially expressed at high levels when the targeting miRNA expression is low. Conversely, the expression of these targets is down-regulated as their targeting miRNAs accumulate. These data support the hypothesis that miRNAs induced during differentiation function to ensure proper cell fate transitions by suppressing leftover stem cell maintenance transcripts in stem cells39. This study demonstrates that miR-9 plays an important role in neural stem cell proliferation and differentiation and that TLX is a key target of miR-9 in neural stem cells. Every miRNA could have multiple target genes23,26, and indeed, several target genes have been predicted for miR-9, including transcription factors REST, FoxG1 and senseless32,33,40,41. One of the questions addressed here is whether the cell proliferation and differentiation effect mediated by miR-9 in neural stem cells is directly related to repression of TLX expression. Transfection of miR-9 into neural stem cells that are stably transduced with a TLX-expressing vector lacking the miR-9 target site showed that such ectopically expressed TLX rescued the proliferative deficiency induced by overexpression of miR-9, and compromised miR-9-induced precocious differentiation. The result of this rescue experiment suggests that miR-9 regulates neural stem cell proliferation and differentiation through repression of TLX expression. While TLX is an important target gene of miR-9, additional targets may also play a role in miR-9 function in neural stem cells. Recent evidence suggests that miRNAs often act as fine-tuning devices rather than as primary gene regulators42. Consistent with this concept, we failed to induce neural differentiation by overexpressing miR-9 alone in cultured neural stem cells. Instead, an accelerated differentiation program was detected when differentiation of neural stem cells was induced in culture or in E13.5 brains, where active endogenous neurogenesis occurs. Furthermore, it has been suggested that inhibiting a miRNA may not generate a strong or even detectable phenotype, as expression of its target genes are already repressed at the transcriptional level, whereas overexpressing a miRNA in cells where its target genes are highly expressed, may render the action of the miRNA more detectable37. In accordance with this theory, we failed to detect a change in cell differentiation in miR-9 antisense RNA-treated neural stem cells (data not shown). However, we were able to detect a precocious differentiation program upon miR-9 overexpression in neural stem cells that were primed for differentiation. In addition to being a direct target of miR-9, TLX also transcriptionally inhibits miR-9 genes, suggesting a negative feedback loop between TLX and miR-9 for a rapid transition from neural stem cells to differentiated cells. In neural stem cells, TLX is expressed at relatively high levels. During differentiation, as TLX levels decrease, miR-9 expression accumulates. MiR-9, in turn, post-transcriptionally suppresses TLX expression to further promote neural differentiation. This regulatory loop may represent a key mechanism to sense the intricate balance between cell proliferation and differentiation and to confer cell fate determination in a timely manner. Overall, our study suggests that the brain-specific miRNA miR-9 plays a key role in vertebrate brain development. MiR-9 provides a novel strategy to control neural stem cell fate determination by forming a feedback regulatory loop with TLX. Methods Neural stem cell culture and differentiation We isolated mouse neural stem cells from adult mouse forebrains using percoll gradient as described16 and cultured in DMEM F12 medium with 1 mM L-glutamine, N2 supplement (Gibco-BRL), EGF (20 ng ml− 1), FGF2 (20 ng ml− 1), and heparin (50 ng ml− 1) for proliferation. For differentiation, we exposed neural stem cells to DMEM F12 media with N2 supplement, 5 μM forskolin and 0.5% (v/v) FBS or 1 μM retinoic acid and 0.5% (v/v) FBS. miR-9 expression vector and reporter construct We amplified miR-9-1 gene by PCR from genomic locus of mouse miR-9-1, which contains the 89 nt hairpin sequences and 200 nt of genomic sequences flanking each side of it. We inserted the 489 nt DNA fragment into a miRNA expression vector, MDH1-PGK-GFP2, to generate miR-9 expression construct. For reporter construct, we subcloned DNA fragments encoding mouse TLX 3′ UTR (1813-3232bp) into psiCHECK 2 (Promega) to make the TLX3′ UTR-siCHECK construct. We created mutant miR-9 target site by site-directed mutagenesis in TLX 3′ UTR-siCHECK vector. We mutated the wild type miR-9 binding site AACCAAAG into TTGGTTTC. To make miR-9-1 reporter construct, we inserted mouse miR-9-1 downstream genomic sequence (1340 bp to 2546 bp downstream of miR-9 hairpin structure), which contains the consensus TLX binding sites, TLX-1/2 and TLX-3, downstream of a Renilla luciferase reporter gene in psiCHECK2 vector. The miR-9-1 mutant reporter construct has the consensus TLX binding site AAGTCA mutated to AGATCA at TLX-1/2 and TLX-3 sites by sequential site-directed mutagenesis. BrdU labeling and immunostaining analysis We seeded mouse neural stem cells at 1 × 105 cells per ml in 4-well chamber slides. We added BrdU to cells 48 hrs after seeding and pulsed for 1 to 2 hrs. The BrdU-treated cells were fixed and acid-treated, followed by immunostaining analysis with BrdU-specific antibody16. We performed immunostaining using antibodies for BrdU (Accurate; diluted 1:1,000), Ki67 (Thermo Scientific, 1:400), nestin (Pharmingen; 1:1000), Tuj1 (Covance, 1:6,000), DCX (Santa Cruz, 1:300), and GFAP (Advance Immuno; 1:500). Transfection, Western blot, and reporter assay We transfected plasmid DNA or DNA/RNA mix using Transfectin (Bio-Rad). We transfected RNA duplexes using SilentFect™ (Bio-Rad). For 50 nM, 100 nM or 200 nM final concentration of miR-9, 0.5 μl, 1 μl or 2 μl of 50 μM RNA duplexes and 1 μl SilentFect™ were mixed in 50 μl media, incubated at room temperature for 20 min, and added dropwise to cells in a 24-well plate with 450 μl medium to a total volume of 500 μl. The transfected cells were harvested 48 hrs after transfection and subjected to subsequent analyses. The wild type miR-9 RNA duplex sense sequence is UCU UUG GUU AUC UAG CUG UAU GA. The mutant miR-9 RNA duplex sense sequence is UGA AAC CAA AUC UAG CUG UAU GA. Western blot of TLX and GAPDH was performed using rabbit anti-TLX antibody (1:1,000) and rabbit anti-GAPDH antibody (Santa Cruz, 1:1,000). We measured Renilla luciferase activity 48 hrs after transfection, normalized it with firefly luciferase or β-galactosidase internal control and expressed it as relative luciferase activity. miRNA Northern blotting We extracted total RNA from tissues or cultured cells by Trizol. We separated 8 μg of RNA on a 10% polyacrylamide gel containing 8M urea and transferred the RNA to Nylon membranes electrophorectically. Membranes were crosslinked by UV irradiation and hybridized overnight with 32P-labeled oligonucleotide probes. We quantified miRNA signals using Phosphor Imager (Molecular Dynamics). DNA probes for Northern blotting include miR-9-antisense probe (as): CAT ACA GCT AGA TAA CCA AAG A and U6-as: TAT GGA ACG CTT CTC GAA TT. RT-PCR analysis We prepared cDNA from total RNA using Omniscript® Reverse Transcription kit (Qiagen) for RT-PCR analyses. Primers for RT-PCR include TLX forward primer: GTC TTT ACA AGA TCA GCT GAT G, reverse primer: ATG TCA CTG GAT TTG TAC ATA TC; GFAP forward primer: GCT ACA TCG AGA AGG TCC GC, reverse primer: GTC TCT TGC ATG TTA CTG GTG; Tuj-1 forward primer: CTG GAG CGC ATC AGC GTA TAC, reverse primer: ATC TGC TGC GTG AGC TCA GG; p21 forward primer: ATG TCC AAT CCT GGT GAT GTC CG, reverse primer: TCA GGG TTT TCT CTT GCA GAA GA; GAPDH forward primer: CAT CAC CAT CTT CCA GGA GC, reverse primer: GCT GTA GCC GTA TTC ATT GTC; actin forward primer: ACC TGG CCG TCA GGC AGC TC, reverse primer: CCG AGC GTG GCT ACA GCT TC. In utero electroporation We performed all animal experiments in accordance with City of Hope and NIH guidelines and regulations. We carried out in utero electroporation as described21. We injected 37.5 pmol of miR-9 or control RNA duplex into the lateral ventricles of embryos along with 0.625 μg of pActin-EGFP reporter plasmid using electroporator CUY-21 (Protech International). The electroporated mice were allowed to survive for 2 days. Brains of embryos were collected and analyzed as described 21. Chromatin immunoprecipitation (ChIP) assays We performed ChIP assays using EZ-ChIP kit (Upstate) with precleaned chromatin from 2×106 mouse neural stem cells and 5 μg antibody for each ChIP assay. Antibodies used include antibodies for TLX, tri-methyl Histone H3 lysine 4 (H3K4me3, Cell Signaling Technology), acetylated histone H3 (AcH3, Cell Signaling Technology), histone deacetylase 5 (HDAC5, Santa Cruz technology), and tri-methyl Histone H3 lysine 9 (H3K9me3, Abcam). Primers for ChIP assays include miR-9-1 TLX-1/2 forward primer: GGT AGG GGT GGT GGG GAT GAA, reverse primer: TCT AGG ATG CCC AAG AAC TTG CT; miR-9-1 TLX-3 forward primer: GCT GGG ACA CTG GGG ATG CTA GA, reverse primer: AGG AGA GAT CCA TGG AGA TAT C; miR-9-1 TLX-4 forward primer: TCC AGG CAG ACA TCC TGC ACT AC, reverse primer: CCT GGT TCT TAG GGA TAC TTC AC. 1 Click here to view.(412K, pdf) Acknowledgments We thank Drs. John Rossi and John Zaia for their critical comments on the manuscript, Dr. Chang-Zheng Chen (Stanford University), Drs Harvey F. Lodish and David P. Bartel (Massachusetts Institute of Technology) for providing the micro RNA expression vector, MDH1-PGK-GFP, and Dr. Qiang Lu (City of Hope) for providing the pEF-pUb-EGFP plasmid. This work was supported by NIH NINDS R01 NS059546 (to Y.S.). Footnotes Author Contributions: Y.S., C.Z, and G.S. designed the project; C.Z., G.S., and S.L. performed the experiments; Y.S., and C.Z. analyzed the data and wrote the manuscript. References 1. McKay R. Stem cells in the central nervous system. Science. 1997;276:66–71. [PubMed] 2. Alvarez-Buylla A, Temple S. Stem cells in the developing and adult nervous system. J Neurobiol. 1998;36:105–10. [PubMed] 3. Gage FH, Kempermann G, Palmer TD, Peterson DA, Ray J. Multipotent progenitor cells in the adult dentate gyrus. J Neurobiol. 1998;36:249–66. [PubMed] 4. Weiss S, van der Kooy D. CNS stem cells: where's the biology (a.k.a. beef)? J Neurobiol. 1998;36:307–14. [PubMed] 5. Ambros V. The functions of animal microRNAs. Nature. 2004;431:350–5. [PubMed] 6. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97. [PubMed] 7. Houbaviy HB, Murray MF, Sharp PA. Embryonic stem cell-specific MicroRNAs. Dev Cell. 2003;5:351–8. [PubMed] 8. Suh MR, et al. Human embryonic stem cells express a unique set of microRNAs. Dev Biol. 2004;270:488–98. [PubMed] 9. Bernstein E, et al. Dicer is essential for mouse development. Nat Genet. 2003;35:215–7. [PubMed] 10. Wienholds E, Koudijs MJ, van Eeden FJ, Cuppen E, Plasterk RH. The microRNA-producing enzyme Dicer1 is essential for zebrafish development. Nat Genet. 2003;35:217–8. [PubMed] 11. Carmell MA, Xuan Z, Zhang MQ, Hannon GJ. The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes Dev. 2002;16:2733–42. [PubMed] 12. Lagos-Quintana M, et al. Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002;12:735–9. [PubMed] 13. Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA. 2003;9:1274–81. [PubMed] 14. Deo M, Yu JY, Chung KH, Tippens M, Turner DL. Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev Dyn. 2006;235:2538–48. [PubMed] 15. Kapsimali M, et al. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol. 2007;8:R173. [PubMed] 16. Shi Y, et al. Expression and function of orphan nuclear receptor TLX in adult neural stem cells. Nature. 2004;427:78–83. [PubMed] 17. Sun G, Yu RT, Evans RM, Shi Y. Orphan nuclear receptor TLX recruits histone deacetylases to repress transcription and regulate neural stem cell proliferation. Proc Natl Acad Sci U S A. 2007;104:15282–7. [PubMed] 18. Zhang CL, Zou Y, He W, Gage FH, Evans RM. A role for adult TLX-positive neural stem cells in learning and behaviour. Nature. 2008;451:1004–7. [PubMed] 19. Roy K, et al. The Tlx gene regulates the timing of neurogenesis in the cortex. J Neurosci. 2004;24:8333–45. [PubMed] 20. Stenman JM, Wang B, Campbell K. Tlx controls proliferation and patterning of lateral telencephalic progenitor domains. J Neurosci. 2003;23:10568–76. [PubMed] 21. Li W, et al. Nuclear Receptor TLX Regulates Cell Cycle Progression in Neural Stem Cells of the Developing Brain. Mol Endocrinol. 2008;22:56–64. [PubMed] 22. John B, et al. Human MicroRNA targets. PLoS Biol. 2004;2:e363. [PubMed] 23. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003;115:787–98. [PubMed] 24. Sempere LF, et al. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004;5:R13. [PubMed] 25. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303:83–6. [PubMed] 26. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15–20. [PubMed] 27. Brennecke J, Stark A, Russell RB, Cohen SM. Principles of microRNA-target recognition. PLoS Biol. 2005;3:e85. [PubMed] 28. Meister G, Landthaler M, Dorsett Y, Tuschl T. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. Rna. 2004;10:544–50. [PubMed] 29. Hutvagner G, Simard MJ, Mello CC, Zamore PD. Sequence-specific inhibition of small RNA function. PLoS Biol. 2004;2:E98. [PubMed] 30. Qian X, et al. Timing of CNS cell generation: a programmed sequence of neuron and glial cell production from isolated murine cortical stem cells. Neuron. 2000;28:69–80. [PubMed] 31. Kim J, et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science. 2007;317:1220–4. [PubMed] 32. Conaco C, Otto S, Han JJ, Mandel G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci U S A. 2006;103:2422–7. [PubMed] 33. Wu J, Xie X. Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol. 2006;7:R85. [PubMed] 34. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell. 2007;128:707–19. [PubMed] 35. Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693–705. [PubMed] 36. Krichevsky AM, Sonntag KC, Isacson O, Kosik KS. Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells. 2006;24:857–64. [PubMed] 37. Cao X, Pfaff SL, Gage FH. A functional study of miR-124 in the developing neural tube. Genes Dev. 2007;21:531–6. [PubMed] 38. Visvanathan J, Lee S, Lee B, Lee JW, Lee SK. The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev. 2007;21:744–9. [PubMed] 39. Farh KK, et al. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science. 2005;310:1817–21. [PubMed] 40. Bredenkamp N, Seoighe C, Illing N. Comparative evolutionary analysis of the FoxG1 transcription factor from diverse vertebrates identifies conserved recognition sites for microRNA regulation. Dev Genes Evol. 2007;217:227–33. [PubMed] 41. Li Y, Wang F, Lee JA, Gao FB. MicroRNA-9a ensures the precise specification of sensory organ precursors in Drosophila. Genes Dev. 2006;20:2793–805. [PubMed] 42. Hornstein E, Shomron N. Canalization of development by microRNAs. Nat Genet. 2006;38(Suppl):S20–4. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Science. 1997 Apr 4; 276(5309):66-71.
[Science. 1997]J Neurobiol. 1998 Aug; 36(2):307-14.
[J Neurobiol. 1998]Nature. 2004 Sep 16; 431(7006):350-5.
[Nature. 2004]Cell. 2004 Jan 23; 116(2):281-97.
[Cell. 2004]Dev Cell. 2003 Aug; 5(2):351-8.
[Dev Cell. 2003]Dev Biol. 2004 Jun 15; 270(2):488-98.
[Dev Biol. 2004]Nat Genet. 2003 Nov; 35(3):215-7.
[Nat Genet. 2003]Nature. 2004 Jan 1; 427(6969):78-83.
[Nature. 2004]Proc Natl Acad Sci U S A. 2007 Sep 25; 104(39):15282-7.
[Proc Natl Acad Sci U S A. 2007]Nature. 2008 Feb 21; 451(7181):1004-7.
[Nature. 2008]J Neurosci. 2004 Sep 22; 24(38):8333-45.
[J Neurosci. 2004]Mol Endocrinol. 2008 Jan; 22(1):56-64.
[Mol Endocrinol. 2008]Mol Endocrinol. 2008 Jan; 22(1):56-64.
[Mol Endocrinol. 2008]PLoS Biol. 2004 Nov; 2(11):e363.
[PLoS Biol. 2004]Cell. 2003 Dec 26; 115(7):787-98.
[Cell. 2003]Curr Biol. 2002 Apr 30; 12(9):735-9.
[Curr Biol. 2002]RNA. 2003 Oct; 9(10):1274-81.
[RNA. 2003]Genome Biol. 2004; 5(3):R13.
[Genome Biol. 2004]Science. 2004 Jan 2; 303(5654):83-6.
[Science. 2004]Cell. 2005 Jan 14; 120(1):15-20.
[Cell. 2005]PLoS Biol. 2005 Mar; 3(3):e85.
[PLoS Biol. 2005]Proc Natl Acad Sci U S A. 2007 Sep 25; 104(39):15282-7.
[Proc Natl Acad Sci U S A. 2007]RNA. 2004 Mar; 10(3):544-50.
[RNA. 2004]PLoS Biol. 2004 Apr; 2(4):E98.
[PLoS Biol. 2004]Mol Endocrinol. 2008 Jan; 22(1):56-64.
[Mol Endocrinol. 2008]Neuron. 2000 Oct; 28(1):69-80.
[Neuron. 2000]Dev Dyn. 2006 Sep; 235(9):2538-48.
[Dev Dyn. 2006]Science. 2007 Aug 31; 317(5842):1220-4.
[Science. 2007]Proc Natl Acad Sci U S A. 2006 Feb 14; 103(7):2422-7.
[Proc Natl Acad Sci U S A. 2006]Genome Biol. 2006; 7(9):R85.
[Genome Biol. 2006]Cell. 2007 Feb 23; 128(4):707-19.
[Cell. 2007]Cell. 2007 Feb 23; 128(4):693-705.
[Cell. 2007]Nature. 2004 Jan 1; 427(6969):78-83.
[Nature. 2004]RNA. 2003 Oct; 9(10):1274-81.
[RNA. 2003]Genome Biol. 2004; 5(3):R13.
[Genome Biol. 2004]Stem Cells. 2006 Apr; 24(4):857-64.
[Stem Cells. 2006]Proc Natl Acad Sci U S A. 2006 Feb 14; 103(7):2422-7.
[Proc Natl Acad Sci U S A. 2006]Cell. 2003 Dec 26; 115(7):787-98.
[Cell. 2003]Cell. 2005 Jan 14; 120(1):15-20.
[Cell. 2005]Proc Natl Acad Sci U S A. 2006 Feb 14; 103(7):2422-7.
[Proc Natl Acad Sci U S A. 2006]Genome Biol. 2006; 7(9):R85.
[Genome Biol. 2006]Dev Genes Evol. 2007 Mar; 217(3):227-33.
[Dev Genes Evol. 2007]Nat Genet. 2006 Jun; 38 Suppl():S20-4.
[Nat Genet. 2006]Genes Dev. 2007 Mar 1; 21(5):531-6.
[Genes Dev. 2007]Nature. 2004 Jan 1; 427(6969):78-83.
[Nature. 2004]Nature. 2004 Jan 1; 427(6969):78-83.
[Nature. 2004]Mol Endocrinol. 2008 Jan; 22(1):56-64.
[Mol Endocrinol. 2008]